Oxford Instruments (OXIG) Trading Update summary

Trading performance and financial highlights

• Achieved strong full-year performance with revenue growth of approximately 9% at constant currency and 6% at actual rates year-on-year.

• Adjusted operating profit expected to rise by about 13% at constant currency (3% at actual rates), aligning with market expectations.

• Group adjusted operating margin anticipated at 17.8% constant currency (16.5% actual), up 70 basis points year-on-year.

• Order intake grew 3% year-on-year at constant currency, reflecting healthy demand.

Divisional performance

• Imaging & Analysis division, contributing two-thirds of revenue and 90% of operating profit, maintained operating margin above 24% at constant currency.

• Semiconductor and materials analysis revenues grew strongly, offsetting softness in healthcare and life science markets.

• Advanced Technologies division delivered strong double-digit revenue growth and returned to profitability, aided by large quantum business orders.

• Compound semiconductor business expanded in its new facility, achieving double-digit revenue growth and margin improvement.

Strategic and operational updates

• Continued focus on operational excellence, commercial execution, and cost management supported results.

• Executed a strategic pivot away from certain market segments in China, adapting to macro volatility.

• Ongoing operational transformation aims to simplify and standardise the business and enhance product profitability.

• Diversified portfolio across multiple growing sectors and geographies underpins resilience and growth.